Welcome to our dedicated page for Lakeside Holding SEC filings (Ticker: LSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Lakeside Holding Limited (Nasdaq: LSH) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. Lakeside identifies itself in these filings as a Nevada-incorporated, U.S.-based integrated cross-border supply chain solution provider and emerging growth company whose common stock trades on The Nasdaq Stock Market LLC.
For investors analyzing LSH, key documents include annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe Lakeside’s cross-border freight solutions under the American Bear Logistics brand and its pharmaceutical distribution activities through Hupan Pharmaceutical (Hubei) Co., Ltd. These reports detail revenue composition between third-party and related-party cross-border freight solutions, the contribution from pharmaceutical product distribution, and revenue by customer geographic location.
Current reports on Form 8-K provide timely information about material events, such as the acquisition of Hupan Pharmaceutical, private placements of common stock, convertible debt financings, Nasdaq listing compliance notices, and changes in directors and executive officers. An 8-K also documents that Lakeside’s common stock is listed on Nasdaq under the symbol LSH and that the company is treated as an emerging growth company. Notifications of late filing on Form 12b-25 (NT 10-Q) explain any delays in quarterly report submissions and the expected timing of those filings.
Lakeside’s proxy materials on Schedule 14A outline proposals for stockholder approval, including amendments to the articles of incorporation and bylaws, increases in authorized common stock, authorization of preferred stock, adoption of a treasury reserve strategy, approval of potential future issuances of common stock or convertible securities, and adoption of equity incentive plans. These documents provide insight into the company’s capital structure and governance framework.
On Stock Titan, AI-generated summaries highlight the main points from each filing, helping readers quickly understand topics such as segment disclosures, financing terms, listing status, and board changes. Real-time updates from EDGAR ensure that new LSH filings, including Forms 10-K, 10-Q, 8-K, DEF 14A, and any insider transaction reports on Form 4, are accessible as soon as they are available, with plain-language explanations to support deeper research into Lakeside’s logistics and pharmaceutical distribution businesses.
Lakeside Holding Limited has resolved a prior Nasdaq listing issue. The company previously received a notice on July 28, 2025 stating that its common stock had traded below the Nasdaq Capital Market’s minimum bid price of $1.00 per share for 30 consecutive business days, from June 12 to July 28, 2025, putting its listing at risk under Nasdaq Listing Rule 5550(a)(2).
On September 29, 2025, Lakeside received a letter from Nasdaq’s Listing Qualifications staff confirming that it has regained compliance with the minimum bid price requirement, and the matter is now closed. This means the company’s common stock, which trades on the Nasdaq Capital Market under the symbol LSH, currently remains in good standing with this specific listing standard.
Lakeside Holding Limited reported leadership and board changes. The board accepted Lan Su’s resignation as Chairman and Chief Operating Officer, effective immediately, while he continues as general manager of subsidiary Hupan Pharmaceutical (Hubei) Co., Ltd. The board elected Yang Li as a director and appointed him Chief Operating Officer and Chairman of the Board, bringing prior CEO, technology, and investment experience.
The board also elected Xiaoou Li as a new independent director to fill a vacancy. She has more than nine years of financial industry experience and has been designated an audit committee financial expert. She will serve on the audit, compensation, and nominating and corporate governance committees. Following these changes, the board has five members, with a majority independent under Nasdaq rules. The company states that Mr. Su’s resignation is not due to any disagreement and that there are no related-party transactions involving the new directors requiring disclosure.
Lakeside Holding Limited reported that board member Ms. Cynthia Vuong resigned from the Board of Directors effective August 15, 2025. She also stepped down from the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee. The company stated that her resignation was not due to any disagreement with the company on its operations, policies, or practices, indicating this is described as a non-conflict departure.
Lakeside Holding Limited filed an amendment to its current report to correct the disclosed terms of a private placement. The amendment restates Item 1.01 and Item 9.01 to show that the aggregate number of shares issued was 2,000,000 (previously reported as 1,500,000) and that the purchase price per share was $0.75 (previously reported as $1.00). The amendment references an Amended Securities Purchase Agreement filed as Exhibit 10.1 (dated August 5, 2025).
Other than these corrections, the Original report filed on July 22, 2025 remains unchanged. The amendment is signed by CFO Long Yi on August 11, 2025. The filing identifies the company as a Nasdaq-listed registrant under the ticker LSH and indicates it is an emerging growth company.
Lakeside Holding Limited entered into a Securities Purchase Agreement to issue an aggregate of 1,807,229 shares of common stock at $0.83 per share, producing gross proceeds of approximately $1,500,000.07. The agreement contains customary representations, warranties and covenants, and the company intends to use the net proceeds for general corporate purposes.
The offering was completed as a private placement relying on exemptions under Section 4(a)(2) and/or Regulation S of the Securities Act; the shares are unregistered and may not be offered or sold in the United States absent registration or an applicable exemption. The form of the Securities Purchase Agreement is filed as Exhibit 10.1.
Lakeside Holding (Nasdaq: LSH) filed a Form 8-K disclosing that on June 24 2025 it executed a Securities Purchase Agreement with several investors for a private placement of 3,000,000 common shares at $1.00 per share, generating approximately $3.0 million in gross proceeds.
The shares are being issued under the Section 4(a)(2)/Regulation S exemptions and therefore are unregistered securities subject to transfer restrictions. Proceeds are earmarked for general corporate purposes. The agreement contains customary representations, warranties and covenants and is included as Exhibit 10.1.
The filing also triggers Item 3.02 disclosure for unregistered sales of equity securities. No additional financial statements, pro-formas, or risk factors were provided, and no other material events were reported.
FAQ
What is the current stock price of Lakeside Holding (LSH)?
What is the market cap of Lakeside Holding (LSH)?
